baber/WOPTO huggingface dataset:
Patent PT-2206644-E (PT)
Title: Submarine
Inventor: TOOBE WERNER
IPC: B63G8/32
Filed: 2009-12-08
Abstract: The submarine has a sluice (2) i.e. torpedo tube, penetrating a pressure hull (4), and pressure-tightly closed at one end by an inner cover (10) and at another end by an outer cover (12). The former end is arranged in the pressure hull, and the latter end is arranged outside the pressure hull. A hydraulic drive (24) is arranged outside the pressure hull for opening and closing the outer cover. The drive is controlled by the pressure hull, and the drive and a securing lug are controlled by a controller i.e. cascade controller.
Patent PT-2259472-E (PT)
Title: A method and an apparatus for determining a data rate in a variable rate packet data wireless communications system in dependence on a traffic to pilot ratio provided by a base station to a mobile station and a pilot signal power measured at the mobi
Inventor: LUNDBY STEIN A
IPC: H04L12/56
Filed: 2001-10-24
Abstract: In a wireless communication system (50) a method for combination transmission of packet data and low delay data. In one embodiment a parallel signaling channel provides a message to receivers (56, 58, 60) indicating a target recipient of packet data. The message also identifies the transmission channel used for packet data transmissions. Each receiver may then selectively decode only packets where the message identifies the receiver as a target recipient. The data packets stored in a buffer are ignored if the target recipient is another mobile unit. In one embodiment, the message is sent concurrently with the data packet on a parallel channel. In one embodiment, the message is punctured into the high rate packet data transmission.
Patent PT-524421-E (PT)
Inventor: FLECKENSTEIN BERNHARD
IPC: A61K39/245
Filed: 1992-06-15
Abstract: The invention relates to the human herpesvirus type 6 protein p100 and parts thereof having its specific immunological properties. It further relates to antibodies directed to them and to the corresponding DNA sequences. They can be used in pharmaceutical or diagnostic compositions, optionally together with other HHV-6 proteins or the corresponding DNA sequences.
Patent PT-716857-E (PT)
Inventor: ARMSTRONG JAY JOSEPH
IPC: C07D498/18
Filed: 1995-11-27
Abstract: This invention provides a method of treating immune related anemia in a mammal which comprises administering rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally.
Patent PT-718917-E (PT)
Inventor: JOHNSON DAVID A
IPC: H01R4/24
Filed: 1995-12-20
Abstract: A connector for electrically interconnecting a lead of a device to a terminal spaced at a distance from the lead. The apparatus includes a housing (20) which has a slot (24) to receive one of each of the one or more contacts (22). The contact-receiving slot extends substantially parallel to an axis which extends between a corresponding lead and spaced terminal. The housing has a first trough (56) formed in it proximate the lead and a second trough (58) formed therein proximate the spaced terminal. A first elastomeric element (76) is received in the first trough formed in the housing, and a second elastomeric element (50) is received in the second trough formed in the housing. The first and second elastomeric elements have a measure of compressibility and tensile extendibility. A contact (22) is received within each slot. Each contact provided has a protrusion (42) which extends outward from the surface of the housing to be engaged by the lead to which it corresponds. Each contact also has a nub (40) which extends outward from the surface to engage the corresponding spaced terminal. Each contact also has first and second hook portions, the first hook portion being disposed proximate the contact protrusion and encircling the first elastomeric element to hold the contact to the first elastomeric element, and the second hook portion being disposed proximate the contact nub and encircling the second elastomeric element to hold the contact to the second elastomeric element. <IMAGE>
Patent PT-714978-E (PT)
Inventor: FROUIN LAURENT
IPC: C09K23/40
Filed: 1995-11-17
Abstract: Gel compsns. comprise: (a) a non-polar medium; (b) a liq. "multicaternary surfactant" (disclosed as having at least two hydrophobic chains attached to a hydrophilic head) which is in acid form and is soluble or dispersible in the medium; (c) neutralising agent present in amt. which is 2-30 (pref. 4-20) times the amt. required to neutralise the surfactant; (d) water in amt. of 0.2-5 (pref. 0.3-3) moles per mole of surfactant, at least part of the water being introduced with surfactant and/or neutralising agent; (e) opt. emulsifier capable of emulsifying the gel to aq. medium; and (f) opt. solid filler that is opt. soluble in medium.
Patent PT-797997-E (PT)
Inventor: BREIPOHL GERHARD
IPC: A61K38/08
Filed: 1997-03-14
Abstract: Use of bradykinin antagonists or their salts for the preparation of drugs to treat chronic fibrogenetic liver disease (liver cirrhosis and liver fibrosis) and acute liver disease, as well as the prevention of complications, is claimed.
Patent PT-790239-E (PT)
Inventor: IKEDA TAKAFUMI
IPC: A61K31/4427
Filed: 1997-01-29
Abstract: A compound of the formula: <CHEM>  and its pharmaceutically acceptable salts, wherein   A<1> and A<2> are each halo or H; X<1> is CH2, CO, SO or SO2; X<2> is CH2 or CO; Y is piperazinyl-(CH2)n-, 2,3,4,5,6,7-hexahydro- 1H-1,4-diazepinyl-(CH2)n- or - N(R<5>)-(CH2)n- wherein R<5> is H or C1-4 alkyl, and n is 0, 1, 2, 3, or 4; R<1> is selected from the following: (a) N-morpholino-C1-4alkylphenyl, C1-4 alkoxycarbonyl, C2-5acyl, dihydroimidazolyl, formamidino, guanidino or dihydroimidazolylamino, etc.; (b) hydrogen, C1-4 alkyl, etc.; (c) piperidinyl; (d) C5-14 cycloalkyl, bicycloalkyl or tricycloalkyl; (e) C7-14 azacyclo-, azabicyclo- or azatricyclo-alkyl; and (f) C7-10 bicycloalkenyl, benzo C5-7 cycloalkyl or heterocyclic, etc., with proviso that when Y is piperazinyl, at least one of A<1> and A<2> is H; X<2> is CH2; and/or R<1> is a group selected from group (a); R<2> is hydrogen, C1-4 alkyl, optionally substituted phenyl, or heterocyclic; and R<3> and R<4> are each C1-5 alkyl. The novel dihydropyridine compounds of this invention have excellent bradykinin antagonistic activity and are thus useful for the treatment of inflammation, cardiovascular diseas, pain, common cold, allergies, asthma, pancreatitis, burns, virus infection, head injury, multiple trauma or the like in mammalian, especially humans.
Patent PT-892111-E (PT)
Title: Aqueous suspensions from mineral materials and their uses
Inventor: BLUM RENE VINZENZ
IPC: C09K23/52
Filed: 1998-07-11
Abstract: Aqueous suspension of mineral materials contains copolymer as dispersion agent and/or to help crush the materials. The copolymer consists of: (a) at least one ethylenically unsaturated monomer with carboxylic group selected from monoacids e.g. (meth)acrylic, (iso)crotonic, and cinnamic; diacids e.g. fumaric and maleic; acid anhydrides such as maleic anhydride; and diacid hemiesters such as 1-4c monesters of maleic acid; (b) optionally at least one unsaturated monomer with a sulphonic group e.g. sodium methallylsulphonate or styrene sulphonic acid; or a phosphoric group e.g. propylene glycol (meth)acrylate phosphate; (c) optionally at least one unsaturated monomer without a carboxylic group e.g. (meth)acrylic esters, (meth)acrylonitrile, styrene, (meth)acrylamide; and (d) at least one unsaturated oxyalkyl monomer with terminal hydrophobic chain of general formula R-Ä-((CH2-CH(R1)-O)m-CH2-CH2-O)n-CH2-CH(R2)pÜq< /SB>-R'. In the formula, m, n, p ≤ 100; q is number such that 0 ≤ q x (n + m + p) ≤ 100; R1, R2 = H, methyl, or ethyl; R = polymerisable unsaturated radical belonging to group of esters including (meth)acrylic, crotonic and vinylphthalic, as well as unsaturated urethanes such as (meth)acrylurethane, or allylurethane; and R' = hydrophobic radical such as tristyrylphenyl,, or 8-30C alkyl, aryl, alkylaryl, arylalkyl, or, when R = urethane, 8C dialkyl, or, better, when R = unsaturated polymerisable radical, ≥ 22C dialkyl amine; total of a + b + c + d = 100 pts. The suspension has specific viscosity no greater than 25. Also claimed are use of the suspension in paper industry, in particular as size for paper.
Patent PT-975951-E (PT)
Inventor: HUTCHINSON PAUL ANDREW
IPC: A01G25/16
Filed: 1998-02-24
Abstract: A detection assembly for detecting moisture within an unsaturated permeable soil or soil-like medium is disclosed which includes a funnel 11 having a surface inclined in use to the vertical for distorting the flow streamlines within the medium to cause an increase in fluid content and saturation at points in the permeable medium; a cup 13 beneath the funnel for collecting free fluid from the saturated permeable medium; a sensor 14 for detecting the presence of free fluid formed upon saturation within the permeable medium, and a vent 16 for venting air from said collection means.
Patent PT-987976-E (PT)
Inventor: CANALE GIUSEPPE
IPC: A47L9/24
Filed: 1998-06-04
Abstract: A telescopic extension (1; 41) for a household appliance comprises an inner tube (2) tightly sliding in an outer tube (3), a sleeve (4; 44), a constraining element (5) between the inner tube (2) and the outer tube (3), a thrust element (6), and an actuator (7). In the extension (1; 41), a tubular end portion (9; 49) associated with the outer tube (3) has a relief (11) forming a niche (12). The sleeve (4; 44) is provided with a projection (15) which is inserted in the niche (12). The sleeve has a hollow (18) wherein the constraining element (5), thrust element (6), and a spring (21) are completely housed. The thrust element (6) is formed by a lengthened, flattened slider (28) provided with a narrow portion (20) having recesses. The actuator (7) has protruding wings (37) provided with inner small teeth (38) which are snap-on coupled with the recesses. (FIG. 1)
Patent PT-962309-E (PT)
Title: Bag making machine and method for manufacturing bags
IPC: B31B50/10
Filed: 1999-04-29
Abstract: The arrangement transports at least two foils (4,6) that are used as sides of the bag. The foils are laid one on the other and joined at the edges of bag. Joined foils are cut along joints to form individual foil bags. Any differences in the foil material are compensated for by stretching the foil with a smaller length for a bag. A measurement arrangement for detecting the quantity of transported foil material contains a number of optical sensors (38,39) of foil markings. An Independent claim is also included for a foil bag production method.
Patent PT-1004638-E (PT)
Inventor: ALBERTO GILLI
IPC: C09D7/80
Filed: 1999-11-25
Abstract: The present invention relates to an aqueous phase paint product and, more specifically, to a process for its application. <??>The process for the application of an aqueous phase paint product comprises the steps of i) preparing an aqueous neutral base containing white flocculi, ii) preparing at least one aqueous coloured base, iii) mixing the aqueous neutral base with the at least one aqueous coloured base to obtain an aqueous paint product, iv) applying by means of a brush the aqueous paint product to a surface to be decorated, and v) smoothing the painted surface.
Patent PT-1107833-E (PT)
Inventor: BAUDHUIN THOMAS J
IPC: B09B3/00
Filed: 1999-03-30
Abstract: Non-hazardous organic waste material is introduced into a slagging combustor where it is burned. The burning produces exhaust gases and a slag of molten, inorganic ash which is removed from the combustor. The exhaust gases are treated to cool and dry the gases and to remove a major portion of particulate matter contained therein. A portion of the treated exhaust gases is mixed with a source of concentrated oxygen in a proportion that results in mixed gases having an oxygen concentration of at least 30% by volume. The mixed gases are introduced into the combustor to support the burning of the waste material. Another portion of the treated exhaust gases is further treated to recover the carbon dioxide therefrom.
Patent PT-1123937-E (PT)
Inventor: SETO HARUO
IPC: C12P17/18
Filed: 1999-10-20
Abstract: A compound which has the following formula (1), <CHEM> a process for its production, a pharmaceutical composition comprising the compound as an active ingredient, a method of treating tumor which comprises administering the compound, use of the compound as a medicine, and a microorganism capable of producing the compound. The compound of the present invention is a novel compound which has antitumor action and is useful as a medicine.
Patent SG-96091-G (SG)
Title: Power-driven cleaning brush
IPC: A46B3/06
Filed: 1991-11-13
Abstract: Power driven cleaning brush (2), e.g. toothbrush, comprising a hollow housing (4) having a handle member (6) and a brush head member (8) with drive train means (50) disposed interiorly thereof. Said drive train menas (50) comprise rack means (52) meshing with tuft holding drive gear means (72,74) which, inturn, drive a serie of tuft holder driven gear means (76-90), said driven gear means meshing with one another. The cleaning brush (2) includes further a sealing device (120,130), a switch assembly (14) and is also combined with a charger support stand assembly (30). The invention describes lastly a system (190), for loading the filament tufts (16,18) into the respective tuft holder members (96,108) of the associated drive and driven gear means (72-90).
Patent IE-800025-L (IE)
Title: Rocking-tyre cooking device
IPC: F24C7/06
Filed: 1980-01-07
Abstract: A cooking device including an open topped vessel having a prismatic form and a polygonal base which is mounted for rotation about a horizontal axis parallel to its length. Motor means for oscillating the vessel in a rocking motion about the axis and a heat source is fixedly mounted above the vessel.
[US4203357A]
Patent IE-43653-L (IE)
Title: Sequestration of oxygen dissolved in water
IPC: C02F1/20
Filed: 1976-01-15
Abstract: A process is disclosed for eliminating oxygen dissolved in water wherein there is added to the water a hydrazine solution containing, as the activator, an amount of a compound of the formula: <IMAGE> WHEREIN A = 0, 1 OR 2; B = 0, 1, 2 OR 3; C = 0, 1, 2 OR 3; B + C = 2 OR 3; AND A + B + C = 3, 4 OR 5, SUFFICIENT TO INCREASE THE RATE OR REMOVAL OF SUCH OXYGEN COMPARED TO THE RATE WHEN AN AQUEOUS HYDRAZINE SOLUTION, PER SE, IS USED.
[US4124500A]
Patent IE-790168-L (IE)
Title: Alarm system
IPC: G08B13/18
Filed: 1979-01-30
Abstract: Intrusion detector of the type in which the presence of an intruder is detected by infrared heat energy emitted by his body. An alarm signal is delivered when the level of radiation detected rises from the ambient level to a threshold level. A temperature responsive circuit adjusts the threshold level and so that the system has a relatively uniform detection range or sensitivity notwithstanding changes in the ambient temperature in the protected area.
[US4195234A]
Patent IE-780178-L (IE)
Title: 11ß-SUBSTITUED STEROIDS
IPC: C07J11/00
Filed: 1978-01-26
Abstract: Novel and biologically active 11 beta -substituted steroids of the oestrane series are disclosed having the formula <IMAGE> (I) wherein (a) R1 is O or ( alpha Y)( beta Z), wherein Y is selected from the group consisting of H, unsaturated aliphatic hydrocarbons of two to about four carbon atoms, saturated aliphatic hydrocarbons of about one to four carbon atoms, and Z is a free, esterified, or etherified hydroxy group; (b) R2 is H and R3 is H or CH3; in the alternative, R2 and R3 together constitute a carbon-carbon bond; and (c) ring A has the structure <IMAGE> wherein R4 in compound (II) is a free, esterified, or etherified hydroxyl group, and R5 in compound (III) is O or is two hydrogens. The new steroids possess oestrogenic, antioestrogenic, progestational, ovulation-inhibiting, uterotropic, androgenic, and anabolic properties for therapeutic administration. Administration may be accomplished via pharmaceutically acceptable compositions containing these compounds in a parenteral, oral or enternal manner (for example, liquid presentations as solutions, suspensions, emulsions, ointments, pastes and solid pharmaceutical presentations such as tablets, pills, capsules and dragees) to take advantage of the recited properties.
[US4292251A]
Patent IE-40595-L (IE)
Title: Prilling.
IPC: B01J2/02
Filed: 1975-02-10
Abstract: When prilling molten materials into a tower containing dust particles suspended or carried in a counter-current gas stream, the amount of dust picked up by the droplets of molten material as they pass down the tower can be reduced by the addition of up to 10% by weight of very fine particles having a primary particle size of less than 1 micrometer to the dust in the tower.
[US3997636A]
Patent IE-44702-L (IE)
Title: Digital correlation receiver
IPC: H04B7/15
Filed: 1977-02-23
Abstract: A digital correlation receiver, particularly for satellite communications transmission, wherein the signal channels or bursts, from various ground stations, combined in a time division multiplex (t.d.m.) arrangement and provided with a preamble comprising a synchronizing word, are time-staggered at the satellite end, and, relative to the reference burst which marks the beginning of the frame, are combined to form a frame and retransmitted with time division multiplex access (TDMA); in which a shift register receives the incoming bit flow at the receiving end and comparators are connected to the individual cells of the shift register, and at whose second comparator inputs a logic state exists representing the synchronizing word to which the received word should correspond, the output of the respective comparators being supplied, in respective combinations, to successive groups of adder stages which are interconnected over corresponding stores, with the respective addition results being supplied to an analysis circuit from which the correlation peak is derived.
[US4112498A]
Patent IE-850432-L (IE)
Title: Pyrido benzothiazines
IPC: C07D513/06
Filed: 1985-02-21
Abstract: Pyridobenzothiazine derivatives with high antimicrobial activity having the following general formula: 
<CHEM>
 wherein
 R is H or CH3; n is 0 or 1 or 2 and Y is Cl or F, 
<CHEM>
 wherein R<1> is a C1-C6 alkyl
 or a C2-C6 alkenyl, or an arylalkyl, arylalkylcarbonyl, alkylcarbonyl, alkyloxycarbonyl, possibly substituted with halogens or hydroxy groups. 
<??>The present invention relates also to the processes for obtaining the compounds having the general formula (I). Such processes consist in synthesis routes using as starting products 3-chloro-4-fluoraniline, or 2,3,4-trifluoronitrobenzene.
Patent IE-820574-L (IE)
Title: Non-isotopic assay
IPC: C07K7/08
Filed: 1982-03-12
Abstract: A highly sensitive, immunoassay method for determining the amount of an analyte in a sample containing a known analyte in an unknown concentration is provided. Sample; a polypeptide-labeled analog of the analyte, an antibody specific for said analyte, a polypeptide partner capable of non-covalently binding with the polypeptide-labeled analyte to form a complex having catalytic activity, and a substrate capable of being converted to a reporter molecule by the catalytic activity of said complex are brought together in a medium. The polypeptide-labeled analyte analog is capable of competitively binding to the antibody and the polypeptide partner, the antibody inhibiting the formation of a catalytically active complex in the absence of analyte, and the concentrations of the antibody, polypeptide partner and polypeptide-labeled analyte are such as to cause varying amounts of analyte to be directly related to the conversion of the substrate to the reporter molecule. Conversion of the substrate to the reporter molecule is then determined, and compared to conversions of substrate to reporter molecule obtained with known concentrations of the analyte.
Patent IE-890939-L (IE)
Title: Organic compounds and their pharmaceutical use
IPC: A61P43/00
Filed: 1989-03-23
Abstract: There are disclosed pharmaceutical compounds of the formula: <CHEM> in which R<1> is halo-substituted alkyl; X is alkenylene; and R<1>-X- contains 6 to 34 carbon atoms; R<2> is C1-5 alkyl substituted by (i) optionally protected carboxyl, nitrile optionally protected tetrazolyl or -CONR min R sec , in which R min and R sec are each hydrogen or C1-4 alkyl, (ii) <CHEM> in which R min and R sec are each hydrogen or C1-4 alkyl, or (iii) <CHEM> in which R min , R sec and R''' are each hydrogen or C1-4 alkyl, or R<2> is a group of the formula <CHEM> in which R min is hydrogen or an optionally protected amino acid residue, and R sec is -OH or an optionally protected amino acid residue; and R<3>, R<4> and R<5> are each hydrogen, optionally protected carboxyl, C1-4 alkyl, C1-4 alkoxy, hydroxyl, optionally protected tetrazolyl, halo, trifluoromethyl, nitrile, nitro or -CONR min R sec where R min and R sec are each hydrogen or C1-4 alkyl; and salts thereof.
[EP0343777A1]
Patent FI-803207-L (FI)
Inventor: ANJOU GUNNAR
IPC: A24F27/00
Filed: 1980-10-09
Abstract: A child-proof container (1) comprising a box (2) and a casing (3), in which the box is insertable, whereby the opening of the box is prevented by means of catch members (4), which in unloaded condition project a small distance into the box from the inner side of one of the flat side surfaces (3a) of the casing, whereby said side of the casing is flexible under influence of side forces (A) acting against each other for raising the catch members above the box (2). (FIG. 1).
Patent FI-852836-L (FI)
Inventor: BULLEN DAVID JOHN
IPC: C08L57/00
Filed: 1985-07-19
Abstract: A crosslinkable thermoplastic polymeric composition comprising a component inherently adapted for crosslinking by thermal or chemical treatment e.g. a peroxide-containing polyolefin component or a silane-modified polyolefin and a fluorocarbon polymer. The composition can be thermoformed to produce useful articles e.g. cable insulation and the presence of the fluorocarbon polymer (e.g. a copolymer of vinylidene fluoride and hexafluoropropylene) results in the articles having improved surface finish.
Patent IE-39276-L (IE)
Title: Hypocholestrolemic compositions
IPC: C07C59/68
Filed: 1974-05-21
Abstract: Calcium alpha -p-chlorophenoxyisobutyrate, particularly as its novel monohydrate, when combined with about one to two parts by weight of calcium carbonate in oral dosage form for use in mammals, and especially man, provides a safe and effective composition for reducing elevated blood levels of cholesterol, triglycerides and/or low density lipoproteins and/or increasing fibrinolytic activity and/or decreasing platelet aggregation. A preferred embodiment is a capsule containing 500 mgm. calcium carbonate and 250 or 500 mgm. crystalline calcium alpha -p-chlorophenoxyisobutyrate monohydrate having the empirical formula C10H10ClO3Ca1/2.H2O.
[US3952096A]
Patent IE-801281-L (IE)
Title: Parental administration using liposomes
IPC: A61K9/50
Filed: 1980-06-20
Abstract: Pharmaceutical compositions useful for the parenteral administration of fat-soluble medicaments are disclosed. The compositions comprise, in addition to the medicaments, a sugar-containing liposome solution or lyophilizates thereof.
[US4411894A]
Patent IE-39801-L (IE)
Title: Novel bicycloalkane derivatives.
IPC: C07C315/04
Filed: 1974-06-20
Abstract: Bicycloalkanes useful as intermediates in the total synthesis of steroids of the formula <IMAGE> WHEREIN N IS THE INTEGER 1 OR 2; R1 is lower-alkyl; X is free or ketalized carbonyl or free, esterified or etherified hydroxymethylene; and Y is -SO2-R2 or -C(Z)(R3)-R4 wherein R2 is alkyl, aryl or aralkyl R3 is H or lower-alkyl, R4 is alkoxycarbonyl or acyl and Z is lower-alkoxycarbonyl, lower acyl, lower alkylsulfinyl or lower-alkylsulfonyl, are produced by the steps of hydrogenating a compound of the formula <IMAGE> AND CONDENSING THE THUS-PRODUCED RING SATURATED COMPOUND WITH A SALT OF THE FORMULA C(Z)(R3)R4<->Me<+> wherein n, X, R1, R2, R3, R4 and Z have the values given above.
[US4017545A]
Patent IE-45170-L (IE)
Title: Ureas and thioureas
IPC: C07C239/00
Filed: 1977-07-19
Abstract: PURPOSE:N-4-Halogenobenzyl-N-methyl-substitute.
[JP53012844A]